Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects

Mise à jour : Il y a 4 ans
Référence : NCT02456558

Femme et Homme

Extrait

This study will evaluate the safety, tolerability, antiretroviral activity, pharmacokinetics, and pharmacodynamics of an intravenous formulation of deferiprone in HIV-infected subjects.


Critère d'inclusion

  • Asymptomatic HIV Infection

Liens